In ten minutes a day, You too can be ON TOP of the biopharma industry
Call John D Waddell, RPh @ +1-610-952-1871
TSM Associates are…
Creative
Experienced
Committed
BioPharma Industry News
-
"47% drop in EBITDA at WPP"
-
"Hospital billing offices are starting to act like used car lots"
-
"Integrating EU and US regulation"
-
"Make primary care worth docs' while"
-
"NEJM: Put comparative effectiveness on labels"
-
"NYT: Docs at top medical schools have been engaging ghostwriters"
-
"Our Health Care Crisis: Age, Obesity, Lawyers"
-
"Polio surge in Nigeria after vaccine virus mutates"
-
"Probing Doctors' Ties to Industry"
-
"Products achieving the greatest sales in first full year on the US market in 2008"
-
"Safety concerns again halt world's first human trial of an embryonic stem cell therapy"
-
"Scrutiny of publication bias increases"
-
"Takeda reacquires Canadian commercial rights to ACTOS from Lilly"
-
"Tauzin to Boener: Don’t "Bully” Me"
-
"The Agenda Behind Mylan's Suit v. the Pittsburgh Post-Gazette"
-
"The future shape of pharma marketing"
-
"The next healthcare battle: cutting Medicare Advantage"
-
"The truth about embryonic stem cells; not safe enough for human trial"
-
"Top pharma executives make Forbes' 'The World's Most Powerful Women'"
-
"US patent office re-examines Plavix patent "
-
"Wal-Mart Uses Connections to Influence Health Care Reform"
-
"Wearable Kidney May One Day Replace Dialysis"
-
"Which Venture Capitalists Are Buying Biotech"
-
"Why Big Pharma Wants To Be Like Big Biotech"
-
"Why Pharma Wants ObamaCare"
-
"Your biggest ally in implemention of social media programs? Legal & Regulatory teams"
-
A Dying Father's Lessons on Life for His Teenaged Daughter - Be sure your involvement and actions' ethics and results will look honorable and wise if they appear in the right hand column of the WSJ - They just might
-
Biologists win Nobel for work on cells' molecular transport
-
Come on, if Lockheed and the US Intelligence Community can manage the risks and leverage Web 2.0, why can't Big Pharma?
-
Compensation incentives driving "sloppier" fourth-quarter NDAs
-
Congress Says Appendectomy is Interstate Commerce but Insurance Sales is Not
-
Corporate venture unit budgets “pocket lint” relative to overall pharmacos' revenue, but essential to ability to access innovative science
-
Covance gets five-year deal to supply genomic analyses to Merck
-
CRM today is good at managing transactions and providing management reports but for the most part, it's a useless burden for salespeople
-
CRMs for sustained-release opioids may include a certification requirement for doctors and pharmacies
-
Death Of Business Intelligence
-
Demand for patents falling as crisis bites: WIPO
-
Doc: I Was Fired for Fighting Hospital's Ties to Medtronic
-
EU moving closer to DTC, pharma industry softens stance on advertising plan
-
Expanding the Primary Care Workforce, An Essential Element of Health Care Reform - Center for American Progress
-
FDA adv panel recs approval of BMS' dapaglifozin in T2D
-
FDA back to seeking direction from lawyers on clinical issues! (see final paragraph - Now we don't have a cart OR a horse?)
-
FDA ZOSYN patent petition decision reaffirms policy on inactive ingredient changes
-
Fewer players but it's still a war in the distribution channel - Motley Fool
-
First H1N1 vaccine available will be MedImmune's FluMist
-
First PCP sales team for Amgen, "mobile reps" for 18-24 month "rotational program" selling bone drug
-
Four month turnaround time for construction of Novavax's Indian pandemic and seasonal flu vaccine plant
-
Gang of 6 headed for clash with Sen Judiciary Chairman over Medical Malpractice Reform
-
Generic drugs get a bad rap. Why? They are the same
-
Google guys correct - IT brings opportunity to every corner of the world - World poverty rates have plummeted 80% since 1970
-
GSK and Pfizer launch ViiV Healthcare, HIV focused JV will undertake "relentless pursuit" of new drugs
-
Helping Elderly Leave Nursing Homes for a Home, States' Initiatives May Even Save a Lot of Money
-
Here's a twist, J&J hints that markets outside the U.S. might suffer a greater proportion of layoffs
-
Highest performing CEOs surprising secrets for winning
-
How Biotechs Can Stand Out in Competition for Big Pharma Partnership
-
HPM Attorney to Speak at Upcoming Conferences on Hatch-Waxman Issues
-
Human Genome Sciences and Vertex Demonstrate, Genomics Are No Longer A Failure
-
Immunomodulator Otelixizumab Appears to Preserve Beta Cell Function in Type 1 Diabetes
-
In diastolic heart failure, statins may worsen symptoms
-
Industry Audit 2009: In contrast to previous downturns, pharma has proved not to be a "safe haven" against recession
-
Innovative project managers use 'think time'
-
Inside China's vaccine laboratories
-
International Committee of Medical Journal Editors (ICMJE) proposes standard, tough conflict-of-interest disclosure form
-
Is the Mayo Clinic a Model Or a Mirage? Jury Is Still Out
-
It's a biosynthetic, engineered assembly line to make molecules that nature doesn't make
-
Japan is an anxious society today.. China’s ambitious society is driven by the collective value of achievements and reward.. India’s catching-up society responds well to collective values of rewards for job well done - McCann CEO
-
Joint Commission Sees Anology for Safety Objectives in Airline Industry
-
Justice Dept says IA hospital crossed line when it paid a handful of specialists up to $1.8M each
-
Lawmakers have turned to.. strategies for reducing spending that merely ratchet down payments rather than fundamentally changing how the health-care system operates - KFF
-
LexisNexis Launches Comprehensive, Web-based Drug Label Database
-
Life cycle venture fund assets down to mid-1990s levels despite 2Q surge
-
Lonza offers $460M for Patheon
-
Los Angeles Medicare spending for the last two years of life double the national average
-
Majority of patients in study of proposed new use for Zimmer spine device were treated by researchers with financial interest in the company
-
Marketing Megatrend: Simple Sells - When it comes to positioning your product the simplest way is always the best way
